Works matching DE "HETEROZYGOUS familial hypercholesterolemia"


Results: 83
    1
    2

    Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia.

    Published in:
    Life (2075-1729), 2025, v. 15, n. 3, p. 506, doi. 10.3390/life15030506
    By:
    • Cefalù, Angelo Baldassare;
    • Nardi, Emilio;
    • Giammanco, Antonina;
    • Gagliardo, Carola Maria;
    • Barbagallo, Carlo Maria;
    • La Grutta, Ludovico;
    • Toia, Patrizia;
    • Brucato, Federica;
    • Scrimali, Chiara;
    • Fasciana, Teresa Maria Grazia;
    • Spina, Rossella;
    • Lanza, Marina;
    • Vitale, Francesco;
    • Noto, Davide;
    • Averna, Maurizio
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study.

    Published in:
    Cardiovascular Drugs & Therapy, 2024, v. 38, n. 1, p. 119, doi. 10.1007/s10557-022-07386-0
    By:
    • Laufs, Ulrich;
    • Birkenfeld, Andreas L.;
    • Fraass, Uwe;
    • Hohenstein, Bernd;
    • Siegert, Carsten;
    • Klotsche, Jens;
    • Steinhagen-Thiessen, Elisabeth;
    • Pittrow, David;
    • Dexl, Stefan;
    • Salmen, Sunnhild;
    • Schettler, Volker J. J.;
    • Parhofer, Klaus G.;
    • Noé, Sebastian;
    • Spengler, Ulrike;
    • Fendler, Franz-Rudolf;
    • Bäumer, Anselm;
    • Schön, Norbert;
    • Unger, Tilman;
    • Taggeselle, Jens;
    • Schwittay, Andreas
    Publication type:
    Article
    10
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    A Comprehensive Review of PCSK9 Inhibitors.

    Published in:
    Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221100107
    By:
    • Coppinger, Caroline;
    • Movahed, Mohammad Reza;
    • Azemawah, Veronica;
    • Peyton, Lee;
    • Gregory, James;
    • Hashemzadeh, Mehrnoosh
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.

    Published in:
    European Heart Journal, 2021, v. 42, n. 32, p. 3063, doi. 10.1093/eurheartj/ehab424
    By:
    • Lopes, Luis R;
    • Garcia-Hernández, Soledad;
    • Lorenzini, Massimiliano;
    • Futema, Marta;
    • Chumakova, Olga;
    • Zateyshchikov, Dmitry;
    • Isidoro-Garcia, Maria;
    • Villacorta, Eduardo;
    • Escobar-Lopez, Luis;
    • Garcia-Pavia, Pablo;
    • Bilbao, Raquel;
    • Dobarro, David;
    • Sandin-Fuentes, Maria;
    • Catalli, Claudio;
    • Querol, Blanca Gener;
    • Mezcua, Ainhoa;
    • Pinilla, Jose Garcia;
    • Rasmussen, Torsten Bloch;
    • Ferreira-Aguar, Ana;
    • Revilla-Martí, Pablo
    Publication type:
    Article
    28

    Current causes of death in familial hypercholesterolemia.

    Published in:
    Lipids in Health & Disease, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12944-022-01671-5
    By:
    • Marco-Benedí, Victoria;
    • Bea, Ana M.;
    • Cenarro, Ana;
    • Jarauta, Estíbaliz;
    • Laclaustra, Martín;
    • Civeira, Fernando
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35

    PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy.

    Published in:
    Biomolecules (2218-273X), 2022, v. 12, n. 4, p. 562, doi. 10.3390/biom12040562
    By:
    • Toscano, Arianna;
    • Cinquegrani, Maria;
    • Scuruchi, Michele;
    • Di Pino, Antonino;
    • Piro, Salvatore;
    • Ferrara, Viviana;
    • Morace, Carmela;
    • Lo Gullo, Alberto;
    • Imbalzano, Egidio;
    • Purrello, Francesco;
    • Squadrito, Giovanni;
    • Scicali, Roberto;
    • Mandraffino, Giuseppe
    Publication type:
    Article
    36
    37
    38

    Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care.

    Published in:
    American Journal of Case Reports, 2023, v. 24, p. 1, doi. 10.12659/AJCR.939489
    By:
    • Kamal, Aisyah;
    • Kanchau, Johanes Dedi;
    • Shahuri, Nur Syahirah;
    • Mohamed-Yassin, Mohamed-Syarif;
    • Baharudin, Noorhida;
    • Razak, Suraya Abdul;
    • Badlishah-Sham, Siti Fatimah;
    • Abdul-Hamid, Hasidah;
    • Aziz, Aznida Firzah Abdul;
    • Al-Khateeb, Alyaa;
    • Chua, Yung An;
    • Kasim, Noor Alicezah Mohd;
    • Kadir, Siti Hamimah Sheikh Abdul;
    • Nawawi, Hapizah;
    • Qureshi, Nadeem;
    • Ramli, Anis Safura
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity.

    Published in:
    Pediatric Nephrology, 2018, v. 33, n. 7, p. 1199, doi. 10.1007/s00467-018-3906-6
    By:
    • Klaus, Günter;
    • Taylan, Christina;
    • Büscher, Rainer;
    • Schmitt, Claus Peter;
    • Pape, Lars;
    • Oh, Jun;
    • Driemeyer, Joenna;
    • Galiano, Matthias;
    • König, Jens;
    • Schürfeld, Carsten;
    • Spitthöver, Ralf;
    • Schaefer, Juergen R.;
    • Weber, Lutz T.;
    • Heibges, Andreas;
    • Klingel, Reinhard
    Publication type:
    Article
    49
    50